QT Imaging Shifts to Direct Sales Model with Key Hires in U.S.
Event summary
- QT Imaging appointed Jason Dyer as VP Regional Sales East and Dave Reinhart as VP Regional Sales West in July 2026.
- The hires mark a shift from distributor-led to direct U.S. commercial strategy for its Breast Acoustic CT Scanner.
- QT Imaging will continue collaborating with NXC Imaging under the existing distribution arrangement.
- The company plans to selectively add further commercial resources in 2027 based on initial success and market feedback.
The big picture
QT Imaging's move to a direct sales model reflects a broader industry trend towards greater control over customer engagement and strategic account development. By strengthening relationships with breast imaging centers, clinicians, and enterprise health systems, the company aims to enhance its gross margin and support long-term growth. The shift also underscores the importance of clinical evidence generation and physician education in driving adoption of innovative medical technologies.
What we're watching
- Execution Risk
- Whether QT Imaging can successfully transition from a distributor-led to a direct sales model without disrupting existing partnerships.
- Market Adoption
- The pace at which QT Imaging can establish relationships with leading medical centers and clinical stakeholders to drive adoption of its technology.
- Strategic Priorities
- How the direct commercial organization will support the development of quantitative imaging biomarkers and therapy monitoring applications.